isavuconazole

A water-soluble triazole prodrug with broad-spectrum antifungal activity. Isavuconazole is absorbed easily, given either orally or intravenously, and… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed efficacy and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2015
Review
2015
Isavuconazole is a new extended-spectrum triazole with activity against yeasts, molds, and dimorphic fungi. It is approved for… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2015
2015
Azole resistance is an emerging problem in Aspergillus fumigatus which translates into treatment failure. Alternative treatments… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2014
2014
We report a patient with relapsed acute myelogenous leukemia after allogeneic stem cell transplantation who developed… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2013
Review
2013
The triazole class of antifungal drugs comprises first-line agents for the treatment of several invasive fungal diseases… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
A 45-year-old male with rhinocerebral mucormycosis (Rhizopus oryzae), refractory to liposomal amphotericin B and posaconazole… (More)
  • table 1
Is this relevant?
2013
2013
Pharmacodynamic (PD) studies with triazoles in the neutropenic murine disseminated candidiasis model have been performed… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 4
  • table 2
Is this relevant?
2009
2009
We evaluated the MICs of isavuconazole (ISAV) against 96 isolates of Aspergillus species and 36 zygomycetes according to the… (More)
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Isavuconazole (BAL4815) is a promising novel broad-spectrum triazole in late-stage clinical development that has proven active in… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2007
2007
Isavuconazole is the active component of the new azole antifungal agent BAL8557, which is entering phase III clinical development… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?